title: [Clinical-immunological and ecological research in diabetic retinopathy].
abstract: Two hundred and ninety-six patients with diabetic retinopathy (DR) were examined: conservative therapy and laser coagulation of the retina were applied in 120 and 176 of them, respectively. The ecological situation in the residence region and its impact on the morbidity and immune status of DR patients were analyzed. The comfort degree of the environment and the level of anthropogenic contamination affect the morbidity and immunogram results. Immune-correctors, i.e. T-activin, sodium nucleinate and laser blood irradiation (LBI), were used within treatment schemes in DR. Laser coagulation of the retina is advisable to assign in combination with sodium nucleinate and LBI in the aftercare of patients concurrently with complex therapy; T-activin is used, within conservative therapy, to correct the unfavorable ecological impact exerted on patient's body.
authors.forename: S E
authors.initials: SE
authors.lastname: Stukalov
authors.forename: M A
authors.initials: MA
authors.lastname: Shchepetneva
authors.forename: V N
authors.initials: VN
authors.lastname: Kornienko
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D001769:Blood / Q000528:radiation effects; D003627:Data Interpretation, Statistical; D003930:Diabetic Retinopathy / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D004463:Ecology; D006801:Humans; D017075:Laser Coagulation; D008875:Middle Aged; D009696:Nucleic Acids / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D011210:Power Plants; D018788:Radioactive Hazard Release; D012106:Research; D012307:Risk Factors; D013949:Thymus Extracts / Q000627:therapeutic use; D014455:Ukraine
chemical_list: D000276:Adjuvants, Immunologic; D009696:Nucleic Acids; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin; C013683:sodium nucleinate